Tycho Peterson
Stock Analyst at Jefferies
(4.66)
# 201
Out of 4,732 analysts
127
Total ratings
64.77%
Success rate
18.35%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Initiates: Buy | $22 | $14.21 | +54.82% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $151.20 | +22.35% | 1 | Dec 10, 2024 | |
| QDEL QuidelOrtho | Initiates: Hold | $43 | $41.74 | +3.02% | 5 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $69.73 | +21.90% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $42 → $54 | $46.00 | +17.39% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $404.00 | +2.72% | 7 | Oct 8, 2024 | |
| TWST Twist Bioscience | Maintains: Underweight | $28 → $35 | $47.56 | -26.41% | 3 | Aug 5, 2024 | |
| RVTY Revvity | Maintains: Hold | $115 → $125 | $118.39 | +5.58% | 1 | Jul 29, 2024 | |
| TXG 10x Genomics | Upgrades: Buy | $24 | $15.08 | +59.15% | 7 | Jul 22, 2024 | |
| PACB Pacific Biosciences of California | Initiates: Buy | $4 | $1.64 | +143.90% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.93 | +55.44% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $158.36 | -10.33% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $36.66 | -12.71% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $136.67 | -15.86% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $12.39 | +61.42% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $559.65 | +16.14% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $1,230 → $1,250 | $1,295.43 | -3.51% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $12.98 | -30.66% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.29 | +424.02% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $8.87 | +576.44% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.12 | +637.18% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $900 | $19.70 | +4,468.53% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $163.50 | +138.53% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $147.36 | +1.79% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $2.82 | +715.60% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.65 | +393.15% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $592.64 | -66.25% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $19.83 | +21.03% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $18.77 | +139.74% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $1.07 | +14,853.27% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $160.51 | -56.39% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $197.36 | -39.20% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.24 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $56.88 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $16.02 | +243.32% | 1 | Jul 19, 2016 |
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $14.21
Upside: +54.82%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $151.20
Upside: +22.35%
QuidelOrtho
Dec 10, 2024
Initiates: Hold
Price Target: $43
Current: $41.74
Upside: +3.02%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $69.73
Upside: +21.90%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $42 → $54
Current: $46.00
Upside: +17.39%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $404.00
Upside: +2.72%
Twist Bioscience
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $47.56
Upside: -26.41%
Revvity
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $118.39
Upside: +5.58%
10x Genomics
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $15.08
Upside: +59.15%
Pacific Biosciences of California
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.64
Upside: +143.90%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.93
Upside: +55.44%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $158.36
Upside: -10.33%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $36.66
Upside: -12.71%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $136.67
Upside: -15.86%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $12.39
Upside: +61.42%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $559.65
Upside: +16.14%
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,295.43
Upside: -3.51%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $12.98
Upside: -30.66%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.29
Upside: +424.02%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $8.87
Upside: +576.44%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.12
Upside: +637.18%
Jun 21, 2021
Initiates: Overweight
Price Target: $900
Current: $19.70
Upside: +4,468.53%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $163.50
Upside: +138.53%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $147.36
Upside: +1.79%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $2.82
Upside: +715.60%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.65
Upside: +393.15%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $592.64
Upside: -66.25%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $19.83
Upside: +21.03%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $18.77
Upside: +139.74%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $1.07
Upside: +14,853.27%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $160.51
Upside: -56.39%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $197.36
Upside: -39.20%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.24
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $56.88
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $16.02
Upside: +243.32%